Physician profile
Min Ren
NPI 1467654798
$2,112.62
in general payments reported to CMS, 2019-2025
18 companies · $584 in 2025
The $584 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $135 · 2021: $337 · 2022: $227 · 2023: $333 · 2024: $383 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,298.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $452.26 | 2022-2025 | |
| Alcon Vision LLC | $420.35 | 2020-2025 | Lensx, Argos, Tryptyr |
| Allergan, INC. | $275.35 | 2019-2022 | |
| Ocular Therapeutix, INC. | $240.70 | 2021-2025 | Dextenza |
| Oyster Point Pharma, INC. | $161.09 | 2022-2024 | Tyrvaya, Ryzumvi |
| Mallinckrodt Hospital Products INC. | $108.01 | 2021-2025 | Acthar |
| Beaver-Visitec International, INC. | $89.29 | 2021 | |
| Glaukos Corporation | $66.95 | 2020-2025 | Idosetr |
| Dompe US, INC. | $59.24 | 2025 | Oxervate |
| Bausch & Lomb Americas INC. | $51.88 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Aerie Pharmaceuticals, INC. | $40.26 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $34.86 | 2019-2020 | |
| Horizon Therapeutics Plc | $21.85 | 2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $21.58 | 2025 | Xdemvy |
| Sight Sciences, INC. | $18.13 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $17.35 | 2021 | |
| Sun Pharmaceutical Industries INC. | $17.09 | 2023 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $16.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Min Ren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.